CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Healthpeak Properties, Inc - DOC CFD

18.11
1.95%
Market Trading Hours* (UTC) Open now
Closes on Monday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.11
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Healthpeak Properties Inc ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 18.46
Open* 18.55
1-Year Change* -11.46%
Day's Range* 18.1 - 18.55
52 wk Range 15.24-28.43
Average Volume (10 days) 5.53M
Average Volume (3 months) 117.83M
Market Cap 10.72B
P/E Ratio 44.85
Shares Outstanding 547.16M
Revenue 2.15B
EPS 0.44
Dividend (Yield %) 6.12245
Beta 1.03
Next Earnings Date Feb 5, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 18.46 -0.04 -0.22% 18.50 18.62 18.41
Apr 11, 2024 18.63 -0.22 -1.17% 18.85 18.86 18.24
Apr 10, 2024 18.62 0.17 0.92% 18.45 18.80 18.39
Apr 9, 2024 19.28 0.31 1.63% 18.97 19.33 18.94
Apr 8, 2024 18.94 0.27 1.45% 18.67 18.98 18.46
Apr 5, 2024 18.57 0.63 3.51% 17.94 18.57 17.94
Apr 4, 2024 18.27 -0.35 -1.88% 18.62 18.76 18.15
Apr 3, 2024 18.33 0.23 1.27% 18.10 18.45 18.02
Apr 2, 2024 18.18 -0.13 -0.71% 18.31 18.38 18.07
Apr 1, 2024 18.48 -0.51 -2.69% 18.99 19.15 18.43
Mar 28, 2024 18.70 0.41 2.24% 18.29 18.74 18.29
Mar 27, 2024 18.27 0.60 3.40% 17.67 18.27 17.63
Mar 26, 2024 17.50 0.09 0.52% 17.41 17.67 17.41
Mar 25, 2024 17.48 0.01 0.06% 17.47 17.70 17.40
Mar 22, 2024 17.48 -0.25 -1.41% 17.73 17.85 17.48
Mar 21, 2024 17.75 0.17 0.97% 17.58 17.87 17.46
Mar 20, 2024 17.52 0.36 2.10% 17.16 17.60 17.16
Mar 19, 2024 17.44 0.25 1.45% 17.19 17.47 17.16
Mar 18, 2024 17.26 0.15 0.88% 17.11 17.33 16.99
Mar 15, 2024 17.18 0.65 3.93% 16.53 17.29 16.53

Healthpeak Properties, Inc Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2061.18 1896.18 1644.88 1240.34 1191.32
Revenue 2061.18 1896.18 1644.88 1240.34 1191.32
Cost of Revenue, Total 858.203 766.235 782.541 405.244 378.657
Gross Profit 1202.97 1129.95 862.334 835.095 812.663
Total Operating Expense 1405.01 1805.65 1373.92 840.623 927.465
Selling/General/Admin. Expenses, Total 98.284 94.693 90.326 87.903 82.796
Depreciation / Amortization 710.569 684.286 553.949 435.191 404.681
Unusual Expense (Income) -262.044 260.437 -52.899 -87.715 61.331
Operating Income 656.166 90.533 270.958 399.716 263.855
Interest Income (Expense), Net Non-Operating -172.944 -157.98 -218.336 -217.612 -261.28
Gain (Loss) on Sale of Assets 9.078 190.59 90.35 -0.04 831.368
Other, Net 14.83 5.224 74.711 -5.744 4.634
Net Income Before Taxes 507.13 128.367 217.683 176.32 838.577
Net Income After Taxes 511.555 131.628 227.106 181.799 842.973
Minority Interest -15.975 -17.851 -14.394 -14.558 -12.294
Equity In Affiliates 1.985 6.1 -66.599 -6.33 -5.755
Net Income Before Extra. Items 497.565 119.877 146.113 160.911 824.924
Total Extraordinary Items 2.884 385.663 267.45 -115.381 236.169
Net Income 500.449 505.54 413.563 45.53 1061.09
Total Adjustments to Net Income -2.657 -3.269 -2.416 -1.543 -2.669
Income Available to Common Excl. Extra. Items 494.908 116.608 143.697 159.368 822.255
Income Available to Common Incl. Extra. Items 497.792 502.271 411.147 43.987 1058.42
Diluted Net Income 497.792 502.271 411.147 43.987 1058.42
Diluted Weighted Average Shares 539.147 539.241 531.056 486.255 475.387
Diluted EPS Excluding Extraordinary Items 0.91795 0.21624 0.27059 0.32775 1.72965
Dividends per Share - Common Stock Primary Issue 1.0168 1.2 1.48 1.48 1.48
Diluted Normalized EPS 0.59639 0.34956 0.00892 0.20985 0.67678
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 545.43 525.678 524.468 520.406 1016.3
Revenue 545.43 525.678 524.468 520.406 1016.3
Cost of Revenue, Total 221.256 220.724 217.277 219.527 421.399
Gross Profit 324.174 304.954 307.191 300.879 594.905
Total Operating Expense 447.999 427.42 152.626 422.082 830.304
Selling/General/Admin. Expenses, Total 25.936 24.547 25.123 24.549 48.612
Depreciation / Amortization 197.573 179.225 179.157 173.19 358.222
Unusual Expense (Income) 3.234 2.924 -268.931 4.816 2.071
Operating Income 97.431 98.258 371.842 98.324 186
Interest Income (Expense), Net Non-Operating -49.074 -47.963 -49.413 -44.078 -79.453
Gain (Loss) on Sale of Assets 4.885 81.578 -0.969 -4.149 14.196
Other, Net 1.364 1.12 -312.025 305.678 21.177
Net Income Before Taxes 54.606 132.993 9.435 355.775 141.92
Net Income After Taxes 53.47 132.691 10.085 359.609 141.861
Minority Interest -4.3 -15.555 -4.274 -4.016 -7.685
Equity In Affiliates 2.729 1.816 -0.156 -0.325 2.466
Net Income Before Extra. Items 51.899 118.952 5.655 355.268 136.642
Total Extraordinary Items 0 0 0.873 -1.298 3.309
Net Income 51.899 118.952 6.528 353.97 139.951
Total Adjustments to Net Income -0.149 -1.254 -0.134 -0.604 -1.919
Income Available to Common Excl. Extra. Items 51.75 117.698 5.521 354.664 134.723
Income Available to Common Incl. Extra. Items 51.75 117.698 6.394 353.366 138.032
Diluted Net Income 51.75 117.698 6.394 353.366 138.032
Diluted Weighted Average Shares 547.294 547.11 537.921 546.015 545.433
Diluted EPS Excluding Extraordinary Items 0.09456 0.21513 0.01026 0.64955 0.247
Dividends per Share - Common Stock Primary Issue 0.3 0.3 0.2542 0.2542 0.5084
Diluted Normalized EPS 0.09363 0.07169 -0.31317 0.6656 0.22403
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Cash and Short Term Investments 72.032 158.287 44.226 144.232 110.79
Cash & Equivalents 72.032 158.287 44.226 144.232 110.79
Total Receivables, Net 53.436 48.691 42.269 59.417 48.171
Accounts Receivable - Trade, Net 53.436 48.691 42.269 59.417 48.171
Total Inventory 108.086
Total Assets 15771.2 15257.5 15920.1 14032.9 12718.6
Property/Plant/Equipment, Total - Net 13260.8 12901.4 11312.1 11205.5 10209.5
Property/Plant/Equipment, Total - Gross 16211.6 15506.7 13528.9 13805 13052.4
Accumulated Depreciation, Total -3188.14 -2839.23 -2409.14 -2771.92 -2842.95
Goodwill, Net
Intangibles, Net 418.061 519.76 519.917 331.693 305.079
Long Term Investments 706.677 403.634 402.871 825.515 540.088
Note Receivable - Long Term 374.832 461.737 249.885 294.321 1584.46
Other Long Term Assets, Total 203.652 183.626 2780.7 617.436 29.056
Other Assets, Total 681.738 580.413 568.111 554.736 -216.625
Payable/Accrued 265.596 227.638 763.391 456.153 391.583
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 9116.53 8742.05 9131.74 7947.83 6774.11
Total Long Term Debt 6407.52 6164.94 6155.37 6347.48 5564.35
Long Term Debt 6407.52 6164.94 6155.37 6347.48 5564.35
Minority Interest 633.576 630.634 556.227 582.416 568.152
Other Liabilities, Total 1273.31 1269.9 1334.25 401.04 246.471
Total Equity 6654.7 6515.47 6788.35 6085.06 5944.44
Common Stock 546.642 539.097 538.405 505.222 477.496
Additional Paid-In Capital 10349.6 10100.3 10229.9 9183.89 8398.85
Retained Earnings (Accumulated Deficit) -4269.69 -4120.77 -3976.23 -3601.2 -2927.2
Other Equity, Total 28.134 -3.147 -3.685 -2.857 -4.708
Total Liabilities & Shareholders’ Equity 15771.2 15257.5 15920.1 14032.9 12718.6
Total Common Shares Outstanding 546.642 539.097 538.405 505.222 477.496
Current Port. of LT Debt/Capital Leases 90.089 5.048 142.605 4.132 3.561
Accrued Expenses 446.432 443.884 179.895 156.611
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Cash and Short Term Investments 63.478 103.78 59.235 72.032 112.452
Cash & Equivalents 63.478 103.78 59.235 72.032 112.452
Total Receivables, Net 59.085 53.467 57.705 53.436 53.964
Accounts Receivable - Trade, Net 59.085 53.467 57.705 53.436 53.964
Total Assets 15602.5 15603.5 15602.3 15771.2 15662
Property/Plant/Equipment, Total - Net 13353.6 13331.3 13322.9 13260.8 13110.2
Property/Plant/Equipment, Total - Gross 16618.2 16477.1 16384 16211.6 16026.1
Accumulated Depreciation, Total -3498.08 -3379.87 -3296.78 -3188.14 -3148.02
Intangibles, Net 339.191 364.453 391.956 418.061 444.215
Long Term Investments 745.381 731.956 714.679 706.677 698.903
Note Receivable - Long Term 225.881 214.03 243.149 374.832 383.991
Other Long Term Assets, Total 58.726 65.027 57.99 104.668 105.995
Other Assets, Total 757.164 739.574 754.723 780.722 752.224
Payable/Accrued 222.673 224.09 265.596 264.451
Accrued Expenses 204.762 406.956 408.573 446.432 397.582
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 87.471 88.765 90.089 1.289
Total Liabilities 9145.23 9068.47 8992.55 9116.53 9195
Total Long Term Debt 6664.41 6481.18 6365.11 6407.52 6589.68
Long Term Debt 6664.41 6481.18 6365.11 6407.52 6589.68
Minority Interest 575.523 590.588 613.899 633.576 659.388
Other Liabilities, Total 1012.88 1279.61 1292.11 1273.31 1282.6
Total Equity 6457.31 6535.06 6609.74 6654.7 6466.96
Common Stock 547.072 547.053 546.995 546.642 537.534
Additional Paid-In Capital 10402 10385 10360.1 10349.6 10014.7
Retained Earnings (Accumulated Deficit) -4528.51 -4428.42 -4316.04 -4269.69 -4114.81
Other Equity, Total 36.747 31.453 18.721 28.134 29.526
Total Liabilities & Shareholders’ Equity 15602.5 15603.5 15602.3 15771.2 15662
Total Common Shares Outstanding 547.072 547.053 546.995 546.642 537.534
Accounts Payable 687.65
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 516.424 525.93 428.253 60.061 1073.47
Cash From Operating Activities 900.261 795.248 758.431 846.073 848.709
Cash From Operating Activities 710.569 684.286 697.143 659.989 549.499
Deferred Taxes -6.001 -5.792 -14.573 -18.253 -18.525
Non-Cash Items -440.534 -440.546 -473.462 102.274 -824.517
Cash Taxes Paid -1.903 4.521 -0.786 1.426 4.48
Cash Interest Paid 162.115 173.044 209.843 201.784 275.69
Changes in Working Capital 119.803 31.37 121.07 42.002 68.778
Cash From Investing Activities -876.343 531.032 -1007.7 -1448.78 1829.28
Capital Expenditures -1039.77 -2093.58 -1962.22 -2231.19 -929.723
Other Investing Cash Flow Items, Total 163.426 2624.61 954.517 782.411 2759
Cash From Financing Activities -116.532 -1288.52 246.45 647.271 -2620.54
Financing Cash Flow Items -33.33 -329.616 -87.823 -76.817 175.26
Total Cash Dividends Paid -648.047 -650.082 -787.072 -720.123 -696.913
Issuance (Retirement) of Stock, Net 240.262 -7.805 1058.35 790.543 214.224
Issuance (Retirement) of Debt, Net 324.583 -301.014 62.997 653.668 -2313.11
Foreign Exchange Effects 0 0 -0.153 0.245 0.191
Net Change in Cash -92.614 37.763 -2.972 44.811 57.643
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 134.507 516.424 505.622 147.636 75.343
Cash From Operating Activities 173.921 900.261 693.306 449.668 194.183
Cash From Operating Activities 179.225 710.569 531.412 358.222 177.733
Deferred Taxes -0.402 -6.001 -5.199 -1.038 -0.079
Non-Cash Items -103.709 -440.534 -428.406 -101.277 -58.56
Cash Taxes Paid 0.16 -1.903 -2.003 -0.612 -1.947
Cash Interest Paid 65.367 162.115 138.972 74.327 58.487
Changes in Working Capital -35.7 119.803 89.877 46.125 -0.254
Cash From Investing Activities 56.345 -876.343 -578.113 -461.136 -245.962
Capital Expenditures -215.108 -1039.77 -776.002 -525.61 -312.352
Other Investing Cash Flow Items, Total 271.453 163.426 197.889 64.474 66.39
Cash From Financing Activities -239.875 -116.532 -165.517 -72.082 -18.511
Financing Cash Flow Items -26.882 -33.33 -26.552 -15.271 -7.276
Total Cash Dividends Paid -164.976 -648.047 -486.96 -325.276 -163.447
Issuance (Retirement) of Stock, Net -6.618 240.262 -67.604 -11.622 -11.356
Issuance (Retirement) of Debt, Net -41.399 324.583 415.599 280.087 163.568
Foreign Exchange Effects 0
Net Change in Cash -9.609 -92.614 -50.324 -83.55 -70.29

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Healthpeak Company profile

About Healthpeak Properties Inc

Healthpeak Properties, Inc. is an integrated real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. The Company acquires, develops, leases, owns, and manages healthcare real estate. Its healthcare segments include Life Science, Medical Office and Continuing Care Retirement Community (CCRC). Under the Life Science and Medical Office segments, the Company invests through the acquisition, development and management of life science buildings, medical office buildings (MOBs), and hospitals. Life science properties are primarily configured in business park or campus settings and include multiple buildings. MOBs also contain physicians’ offices and examination rooms, diagnostic centers, rehabilitation clinics, and day-surgery operating rooms. CCRC segment, which includes independent living, assisted living, and skilled nursing units to provide a continuum of care in an integrated campus.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Healthpeak Properties Inc revenues increased 15% to $1.9B. Net income applicable to common stockholders excluding extraordinary items decreased 19% to $116.6M. Revenues reflect Life Science segment increase of 26% to $715.8M. Net income was offset by Net Operating Income (NOI)-Other Non Rep decrease of 15% to $17.5M, Gain (loss) on debt extinguishments increase from $42.9M to $225.8M (expense).

Equity composition

Common Stock $1 Par, 04/11, 750M auth., 406,026,946 issd. Insiders & Strategic holders own 0.20%. PO 2/95, 1.5M shs. @ $29 by Merrill Lynch. PO 5/85, 3.8M shs. @ $20 by Merrill Lynch. PO 12/97, 1.25M shs. @ $38.3125 by Merrill Lynch. PO 3/08, 4.5M shares @ $33.32 by Goldman, Sachs & Co. 09/07, Name changed from Health Care Property Investors,

Industry: Healthcare REITs

4600 South Syracuse Street
Suite 500
DENVER
COLORADO 80237
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

XRP/USD

0.50 Price
+0.980% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

17,753.10 Price
-1.600% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,092.61 Price
+0.350% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

63,759.60 Price
-0.650% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading